rs74315438
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The ENST00000399135.6(CLDN14):c.301G>A(p.Gly101Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,613,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000399135.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLDN14 | NM_001146079.2 | c.301G>A | p.Gly101Arg | missense_variant | 2/2 | ENST00000399135.6 | NP_001139551.1 | |
CLDN14-AS1 | NR_183529.1 | n.468+15388C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLDN14 | ENST00000399135.6 | c.301G>A | p.Gly101Arg | missense_variant | 2/2 | 1 | NM_001146079.2 | ENSP00000382087 | P1 | |
CLDN14-AS1 | ENST00000428667.1 | n.277+15388C>T | intron_variant, non_coding_transcript_variant | 5 | ||||||
LNCTSI | ENST00000429588.1 | n.54-18836C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000404 AC: 10AN: 247596Hom.: 0 AF XY: 0.0000447 AC XY: 6AN XY: 134184
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1460888Hom.: 0 Cov.: 34 AF XY: 0.0000303 AC XY: 22AN XY: 726778
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74350
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 29 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2005 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Apr 27, 2019 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 16, 2024 | Published functional studies suggest the variant may impair polymerization of the CLDN14 protein and interfere with the formation of tight junction strands, however additional studies are needed to determine the significance of this effect (Wattenhofer M et al., 2005); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 31589614, 31527509, 27838790, 22246673, 24752540, 29447821, 15880785, 38790217, 33105617) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 17, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 101 of the CLDN14 protein (p.Gly101Arg). This variant is present in population databases (rs74315438, gnomAD 0.008%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects CLDN14 function (PMID: 15880785). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 4852). This missense change has been observed in individual(s) with deafness (PMID: 15880785, 33105617; Invitae). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at